Reuters logo
BRIEF-Allergan says FDA accepts NDA for Ulipristal Acetate for Uterine Fibroids
2017年10月10日 / 下午12点30分 / 14 天内

BRIEF-Allergan says FDA accepts NDA for Ulipristal Acetate for Uterine Fibroids

Oct 10 (Reuters) - Allergan Plc:

* Announces FDA accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids

* Expects Ulipristal Acetate Prescription Drug User Fee Act action date to occur in first half of 2018 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below